Overcoming Antibiotic Resistance with Novel Paradigms of Antibiotic Selection
- PMID: 36557636
- PMCID: PMC9781420
- DOI: 10.3390/microorganisms10122383
Overcoming Antibiotic Resistance with Novel Paradigms of Antibiotic Selection
Abstract
Conventional antimicrobial susceptibility tests, including phenotypic and genotypic methods, are insufficiently accurate and frequently fail to identify effective antibiotics. These methods predominantly select therapies based on the antibiotic response of only the lead bacterial pathogen within pure bacterial culture. However, this neglects the fact that, in the majority of human infections, the lead bacterial pathogens are present as a part of multispecies communities that modulate the response of these lead pathogens to antibiotics and that multiple pathogens can contribute to the infection simultaneously. This discrepancy is a major cause of the failure of antimicrobial susceptibility tests to detect antibiotics that are effective in vivo. This review article provides a comprehensive overview of the factors that are missed by conventional antimicrobial susceptibility tests and it explains how accounting for these methods can aid the development of novel diagnostic approaches.
Keywords: TezR; antibiotic resistance; antimicrobial susceptibility tests; bacterial pathogens; biofilm; collective antibiotic resistance; persisters.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Phenotypic and genotypic characterization of biofilm producing clinical coagulase negative staphylococci from Nepal and their antibiotic susceptibility pattern.Ann Clin Microbiol Antimicrob. 2021 May 31;20(1):41. doi: 10.1186/s12941-021-00447-6. Ann Clin Microbiol Antimicrob. 2021. PMID: 34059077 Free PMC article.
-
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.Cochrane Database Syst Rev. 2020 Jun 10;6(6):CD009528. doi: 10.1002/14651858.CD009528.pub5. Cochrane Database Syst Rev. 2020. PMID: 32520436 Free PMC article.
-
Host metabolites stimulate the bacterial proton motive force to enhance the activity of aminoglycoside antibiotics.PLoS Pathog. 2019 Apr 29;15(4):e1007697. doi: 10.1371/journal.ppat.1007697. eCollection 2019 Apr. PLoS Pathog. 2019. PMID: 31034512 Free PMC article.
-
Repeated exposure of nosocomial pathogens to silver does not select for silver resistance but does impact ciprofloxacin susceptibility.Acta Biomater. 2021 Oct 15;134:760-773. doi: 10.1016/j.actbio.2021.07.056. Epub 2021 Jul 28. Acta Biomater. 2021. PMID: 34329788
-
Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection.Cochrane Database Syst Rev. 2021 May 4;5(5):CD013235. doi: 10.1002/14651858.CD013235.pub2. Cochrane Database Syst Rev. 2021. PMID: 34097767 Free PMC article.
Cited by
-
Prevalence and pattern of antibiotic use and resistance among Iraqi patients: a cross-sectional study.Afr Health Sci. 2024 Sep;24(3):47-57. doi: 10.4314/ahs.v24i3.7. Afr Health Sci. 2024. PMID: 40777977 Free PMC article.
-
AtbFinder Diagnostic Test System Improves Optimal Selection of Antibiotic Therapy in Persons with Cystic Fibrosis.J Clin Microbiol. 2023 Jan 26;61(1):e0155822. doi: 10.1128/jcm.01558-22. Epub 2023 Jan 5. J Clin Microbiol. 2023. PMID: 36602344 Free PMC article.
-
A new model of endotracheal tube biofilm identifies combinations of matrix-degrading enzymes and antimicrobials able to eradicate biofilms of pathogens that cause ventilator-associated pneumonia.Microbiology (Reading). 2024 Aug;170(8):001480. doi: 10.1099/mic.0.001480. Microbiology (Reading). 2024. PMID: 39088248 Free PMC article.
-
Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.Sci Rep. 2023 Jan 9;13(1):449. doi: 10.1038/s41598-023-27723-z. Sci Rep. 2023. PMID: 36624272 Free PMC article.
-
Pooled Antibiotic Susceptibility Testing for Polymicrobial UTI Performs Within CLSI Validation Standards.Antibiotics (Basel). 2025 Feb 1;14(2):143. doi: 10.3390/antibiotics14020143. Antibiotics (Basel). 2025. PMID: 40001387 Free PMC article.
References
-
- Talebi Bezmin Abadi A., Rizvanov A.A., Haertlé T., Blatt N.L. World Health Organization Report: Current Crisis of Antibiotic Resistance. Bionanoscience. 2019;9:778–788. doi: 10.1007/s12668-019-00658-4. - DOI
-
- Dobbin C., Maley M., Harkness J., Benn R., Malouf M., Glanville A., Bye P. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: Results from a single large referral centre. J. Hosp. Infect. 2004;56:277–282. doi: 10.1016/j.jhin.2004.01.003. - DOI - PubMed
-
- Somayaji R., Parkins M.D., Shah A., Martiniano S.L., Tunney M.M., Kahle J.S., Waters V.J., Elborn J.S., Bell S.C., Flume P.A., et al. Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic review. J. Cyst. Fibros. 2019;18:236–243. doi: 10.1016/j.jcf.2019.01.008. - DOI - PubMed
-
- Waters V.J., Kidd T.J., Canton R., Ekkelenkamp M.B., Johansen H.K., LiPuma J.J., Bell S.C., Elborn J.S., Flume P.A., VanDevanter D.R., et al. Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections. Clin. Infect. Dis. 2019;69:1812–1816. doi: 10.1093/cid/ciz364. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources